Supernus adjusted the conversion rate of its 0.625% Convertible Senior Notes due 2031 from 24.0033 to 30.9355 shares per $1,000 principal amount, reflecting a new conversion price of approximately $32.33 per share. This adjustment was triggered by the special dividend declared on September 16, 2026. No bondholders converted their bonds for common stock as of this report. Supernus operates in the pharmaceutical industry.
